Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial
DTG and ATV/r were associated with greater gains in fat-free mass and muscle mass than LPV/r, while DRV/r, TAF and prior nevirapine exposure were associated with fat mass accrual. Fat gain may initially reflect return to health but sustained increases may have metabolic implications. These findings suggest the need to monitor fat compartments with long-term exposure.
Authors
- Grace Ndeezi
- Spencer Byaruhanga
- Ann Sarah Walker
- Esther Nambi
- Alex J. Szubert
- Abbas Lugemwa
- Victor Musiime
- Mary Nyathi
- Diana M. Gibb
- Philippa Musoke
Institutions
- University of Zimbabwe (ZW)
- Mpilo Central Hospital (ZW)
- University of Zambia (ZM)
- MUJHU Research Collaboration (UG)
- Joint Clinical Research Centre (UG)
- University College London (GB)
- Makerere University (UG)
- Medical Research Council (GB)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1097/inf.0000000000005195
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00